
Niharika Bansal Mettu
Associate Professor of MedicineOverview
My long-term goal is to develop new therapies to treat patients with gastrointestinal and other solid tumors. To accomplish this, I am active in designing, writing, and running phase I and II clinical trials. I am also interested in the correlative science that furthers our understanding of cancer at a molecular level. I am interested in the identification of biomarkers, which are characteristics of a given patient's tumor that may help us to understand his or her prognosis or how well he or she may respond to a given therapy. The overall objective of this research is to use the knowledge gained to personalize care and find the very best therapies that will enable our patients to fight their cancer.
Positions
Associate Professor of Medicine in the School of Medicine
2023 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2017 School of Medicine
Education
Ph.D., Duke University 2007
2007 Duke University
M.D., Duke University, School of Medicine 2008
2008 Duke University, School of Medicine
Internal Medicine Residency, Duke University, School of Medicine, MEDICINE 2008 - 2011
2011 Duke University, School of Medicine
Hematology-Oncology Fellowship, Duke University, School of Medicine, MEDICINE 2011 - 2014
2014 Duke University, School of Medicine
Clinical Trials
EAY191-S3 Advanced non-breast solid tumors with AKT-alterations
EAY191-A3 (RAS-Mutant Cancers)
RASolute 302: RMC-6236 vs SOC in PDAC (Pancreatic Cancer)
AMG 193 + Other Therapies in Advanced GI & PDAC with homozygous MTAP-deletion (20230223)
A Ph 1/2 of PC14586 in Patients with Advanced or Metastatic Tumors w/ TP53 Y220C Mutation
Ph 1 Study of PF-07934040 in Subjects with Adv Solid Tumors with KRAS Mutation
PHST001 in adult patients with advanced relapsed and/or refractory solid tumors
Publications, Grants & Awards
- Grants (41)
- Academics Articles (63)
- Conference Pages (1)
DCI Centers, Cancer Types & Labs
Offices & Contact
Durham, NC
27710
Durham, NC
27710